COMMUNIQUÉ DE PRESSE publié le 08/01/2024 à 22:00, il y a 1 année 10 mois Jovive Launches Two New Outpatient Wound Care Clinics in Southern California Jovive, a provider of patient-centric outpatient healthcare services owned by Vituity, announces the opening of Jovive Wound Care outpatient clinics in Mission Viejo and Loma Linda, CA. These specialized clinics aim to deliver comprehensive wound care services in an outpatient setting to enhance patient outcomes and improve quality of life, while minimizing the risk of infections and reducing the total cost of care. Through technology, training, and proven protocols, Jovive Wound Care aims to achieve enduring results and provide cost-effective care to the Southern California communities. Learn more at JoviveWoundCare.com. Jovive Wound Care Outpatient Clinics Comprehensive Wound Care Southern California Patient-centric Healthcare
COMMUNIQUÉ DE PRESSE publié le 19/12/2023 à 23:00, il y a 1 année 11 mois Vituity Cares Foundation Celebrates Success at 2023 Healing Voices Annual Gala
Publié le 04/12/2025 à 18:14, il y a 13 heures 43 minutes Résiliation d'une convention conclue entre actionnaires
Publié le 04/12/2025 à 18:00, il y a 13 heures 58 minutes Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Publié le 04/12/2025 à 18:00, il y a 13 heures 58 minutes Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Publié le 04/12/2025 à 17:45, il y a 14 heures 13 minutes Informations relatives au nombre total de droits de vote et d’actions
Publié le 04/12/2025 à 17:45, il y a 14 heures 13 minutes MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Publié le 05/12/2025 à 02:35, il y a 5 heures 23 minutes Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Publié le 05/12/2025 à 01:00, il y a 6 heures 58 minutes BEACN Closes First Tranche of Non-Brokered Private Placement
Publié le 04/12/2025 à 23:05, il y a 8 heures 53 minutes BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Publié le 04/12/2025 à 23:00, il y a 8 heures 58 minutes NXT Energy Solutions Completes Data Acquisition for SFD Survey
Publié le 05/12/2025 à 07:00, il y a 57 minutes Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Publié le 05/12/2025 à 03:30, il y a 4 heures 27 minutes CGTN: What makes cooperation between China and France a two-way success
Publié le 04/12/2025 à 23:50, il y a 8 heures 7 minutes EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Publié le 04/12/2025 à 20:25, il y a 11 heures 32 minutes Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Publié le 04/12/2025 à 20:15, il y a 11 heures 42 minutes Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
